Related Experiment Video
Updated: Nov 24, 2025
10:14
Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
3.9K
Patchy hyperautofluorescence as a predictive factor for the recurrence of punctate inner choroidopathy
Yuhong Gan1, Yongyue Su1, Yuxin Zhang1
1State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, 54 South Xianlie Road, Guangzhou, China.
Photodiagnosis and Photodynamic Therapy
|December 28, 2020
Summary
Recurrence of punctate inner choroidopathy (PIC) is common and linked to poorer vision. Baseline patchy hyperautofluorescence on imaging indicates a higher risk of PIC recurrence, suggesting closer monitoring is needed.
Area of Science:
- Ophthalmology
- Medical Imaging
- Retinal Diseases
Background:
- Punctate inner choroidopathy (PIC) is an inflammatory eye condition.
- Understanding factors predicting PIC recurrence is crucial for patient management.
- Recurrence can negatively impact visual outcomes in PIC patients.
Purpose of the Study:
- To identify baseline clinical and imaging predictors of punctate inner choroidopathy (PIC) recurrence.
- To assess the correlation between initial diagnostic findings and subsequent inflammatory episodes in PIC.
Main Methods:
- Retrospective observational study of 45 patients with active PIC.
- Multimodal imaging (MMI) including SD-OCT, FAF, FFA, and ICGA analyzed at baseline.
- Statistical analysis to correlate clinical and MMI parameters with PIC recurrence.
Main Results:
- 40% of patients experienced PIC recurrence during follow-up (mean 23.66 months).
- Recurrence was associated with significantly different final best-corrected visual acuity (BCVA).
- Patchy hyperautofluorescence at baseline was significantly more prevalent in patients with recurrence (P<0.001).
Conclusions:
- Recurrence of PIC is frequent and associated with worse visual acuity.
- Baseline patchy hyperautofluorescence is a significant risk factor for PIC recurrence.
- Patients with patchy hyperautofluorescence may require vigilant follow-up despite initial inflammation resolution.
